Zepbound Savings Card vs Compounded Tirzepatide: Which Saves You More in 2026?
Lilly’s “pay-as-little-as $25” coupon looks unbeatable-until you read the small print or lose eligibility. Use this guide to compare the real-world math against popular compounded tirzepatide programs.
The 2026 Zepbound savings card lets eligible commercially-insured patients pay as little as $25 for up to a three-month fill, while compounded tirzepatide programs typically run $200–$325 per month before shipping. Once you exceed the card’s caps, switch to Medicare’s new $50 out-of-pocket limit, or fall back on LillyDirect self-pay prices ($299–$499), the break-even point depends on the weekly dose you’re injecting. Use the calculator below to see whether brand-name Zepbound or a compounded option is cheaper at your current dose.
- The Zepbound savings card expires on December 31, 2026 and lowers the pharmacy price to $25 per 1-, 2-, or 3-month fill for eligible patients. (zepbound.lilly.com)
- Medicare beneficiaries will pay no more than $50 a month for Zepbound starting April 1, 2026. (investor.lilly.com)
- Most compounded tirzepatide clinics advertise monthly medication costs of $200–$325, often plus a $50-$100 membership fee. (statnews.com)
- Zepbound doses range from 2.5 mg to 15 mg once weekly, or 10 mg to 60 mg of drug per month. (accessdata.fda.gov)
- Patients lose Zepbound coupon eligibility if they use Medicare, Medicaid, Tricare, or exceed Lilly’s annual maximum benefit of $3,000.
What the Zepbound savings card is - a quick definition
The Zepbound savings card is a manufacturer coupon from Eli Lilly that reduces out-of-pocket costs to as little as $25 per monthly prescription for commercially-insured adults with coverage for Zepbound. The card functions as secondary insurance at the pharmacy counter and automatically applies until you reach Lilly’s annual maximum benefit (currently $3,000) or the program’s December 31, 2026 expiration date. (zepbound.lilly.com)
Eligibility basics: You must be 18 years or older, reside in the United States or Puerto Rico, have commercial drug coverage for Zepbound, and not be enrolled in any federal health-care program (Medicare, Medicaid, VA, DoD, or Tricare). Government-insured patients are slated to use the separate $50 Medicare cap beginning April 1, 2026. (investor.lilly.com)
How much brand-name Zepbound really costs in 2026
With the $25 savings card, Zepbound is almost always the cheapest option. Without it, your price depends on insurance coverage, LillyDirect self-pay programs, or the drug’s list price.
| Scenario (2026) | Patient pays per month* | Key limits |
|---|---|---|
| Commercial insurance + savings card | $25 | Expires 12/31/2026; annual max $3,000 benefit (zepbound.lilly.com) |
| Medicare (Part D) after April 1, 2026 | $50 | Applies to all doses dispensed through Medicare plans (investor.lilly.com) |
| LillyDirect Self-Pay Pen (lowest dose) | $299 | 2.5 mg multi-dose pen; online only (investor.lilly.com) |
| LillyDirect Self-Pay Pen (higher doses) | $449 | Up to 15 mg multi-dose pen; online only (investor.lilly.com) |
| LillyDirect Self-Pay Single-dose vial | $499 | 7.5 mg or 10 mg vial pricing (investor.lilly.com) |
| Wholesale acquisition cost (WAC) list price | ≈$1,060 | Subject to pharmacy markup; rarely paid after rebates |
| *Monthly cost assumes one 28-day supply (4 injections). | ||
For most insured patients, the coupon trumps every other route. But once you hit the $3,000 annual subsidy (that’s roughly 10 months at $25/month), costs jump to your plan’s copay or to self-pay pricing.
What compounded tirzepatide programs charge in 2026
Compounded tirzepatide typically costs $200–$325 for a 30- to 50-mg vial, plus any membership or consultation fees. A 2025 STAT investigation reported compounded GLP-1 prices “about $200 a month,” while Lilly’s 2025 lawsuit against Mochi Health documented Instagram ads pitching “generic tirzepatide” for $275–$325 per month. (statnews.com)
| Program model | Medication fee (monthly) | Visit/Membership fee | Shipping |
|---|---|---|---|
| Telehealth clinic (e.g., Mochi) | $275-$325 | $25-$50 | Often included |
| Local weight-loss clinic | $200-$250 | $50-$100 | Pickup in office |
| 503B Outsourcing facility direct | $220-$260 | $0-$25 | $20 cold-chain |
Most compounders ship a single multidose vial. At a common maintenance dose of 10 mg once weekly (40 mg per month), a $300 vial equals about $7.50 per mg-information you’ll need for the calculator below.
Price-shop every pharmacy in seconds
Use Rx.com to compare cash prices at 60,000+ U.S. pharmacies-most patients pay far less than the list price with our free discount card.
Break-even calculator: when does compound beat brand?
The pivot point is the per-mg cost once the $25 coupon is off the table. At lower doses, LillyDirect’s $299 coupon-free pen is actually cheaper per mg than many compounders. Above about 7.5 mg weekly, compounded vials regain the edge.
| Weekly dose | Monthly mg | Zepbound with $25 card | Zepbound self-pay ($299-$449) | Compounded ($300) | Cheapest |
|---|---|---|---|---|---|
| 5 mg | 20 mg | $1.25 / mg | $14.95 / mg | $15.00 / mg | $25 card |
| 7.5 mg | 30 mg | $0.83 / mg | $9.97 / mg | $10.00 / mg | $25 card |
| 10 mg | 40 mg | $0.63 / mg | $7.48 / mg | $7.50 / mg | $25 card |
| 12.5 mg | 50 mg | $0.50 / mg | $5.98 / mg | $6.00 / mg | $25 card |
| 15 mg | 60 mg | $0.42 / mg | $7.48 / mg* | $5.00 / mg | Compound |
| *Assumes $449 pen price; the $499 vial yields $8.32 / mg. | |||||
How to use this table: Find your weekly dose and read across. If the coupon applies, brand wins every time. If you’re self-paying, circle the lowest per-mg number to pick the cheaper option.
Still not sure which path to take?
Check the column that fits your situation:
✅ Stick with branded Zepbound
- You have commercial insurance and haven’t hit the $3,000 coupon limit
- Your weekly dose is 10 mg or less and you can access LillyDirect’s $299 pen
- You prefer FDA-approved medication with standardized potency and no additives
🏥 Consider compounded tirzepatide
- You lost coupon eligibility (Medicare, Medicaid, Tricare, or annual cap)
- Your maintenance dose is 12.5 mg or 15 mg weekly
- You can verify the pharmacy’s 503A/503B sterile compounding license
- You understand compounded drugs are not FDA-approved and accept the risk
Why compounded tirzepatide carries extra risk
Compounded GLP-1 drugs are legal only under narrow conditions and are not reviewed by the FDA for safety, efficacy, or quality. The agency warns that unapproved versions may arrive warm, include undisclosed additives, or be made by facilities lacking sterile licenses. (fda.gov)
Quality concerns: A July 2026 JAMA Health Forum study found that 19 % of compounders supplying GLP-1 injectables in two states lacked sterile compounding licenses, and 13 % faced disciplinary action since 2023. (jamanetwork.com)
Additives and potency: Many clinics mix tirzepatide with B-vitamins, niacinamide, or levocarnitine-none of which are in FDA-approved Mounjaro or Zepbound pens. These changes can alter viscosity, stability, and absorption.
💡 Looking for more detail on GLP-1 safety?
Read our deep dive Are GLP-1 Medications Safe? to understand thyroid warnings, pancreatitis risk, and how to monitor labs.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe abdominal pain - could signal pancreatitis or gallstones
- Persistent nausea or vomiting - risk of dehydration and electrolyte imbalance
- Signs of thyroid tumor - neck swelling, hoarseness, or trouble swallowing
- Vision changes - may indicate diabetic retinopathy progression
- Hypoglycemia - sweating, confusion, shakiness on combination therapy with sulfonylureas or insulin
- Allergic reaction - rash, itching, trouble breathing after injection
- Warm or cloudy injection solution - possible contamination, especially with compounded vials
- Thoughts of self-harm - call or text the 988 Suicide & Crisis Lifeline 24/7
Scientific References
- Eli Lilly. Zepbound Savings & Insurance Options. Accessed August 2026.
- Eli Lilly. Lilly and U.S. Government Agree to Expand Access to Obesity Medicines. Press release, November 6, 2025.
- FDA. Zepbound (tirzepatide) Prescribing Information. Updated 2026.
- Palmer K, Chen E. Patients struggle as compounded GLP-1 access rapidly shrinks. STAT News. April 29, 2025.
- FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. April 2026.
- Farrell J G, et al. Post-shortage Compounded GLP-1 RA Market in Two States. JAMA Health Forum. 2026;7:e262207.
- Eli Lilly v. Mochi Health Corp. Complaint. U.S. District Court, N.D. California. Filed April 23, 2025.
Frequently Asked Questions
Can I stack the Zepbound savings card with a pharmacy coupon?
No. The savings card must be processed as secondary insurance, and most pharmacies will not apply additional discount cards on the same claim.
Does the $25 coupon cover the new multi-dose pen?
Yes, as long as the NDC on the prescription matches one of the eligible single-patient-use pens listed in the program terms.
What happens after I hit the $3,000 annual maximum benefit?
The coupon stops applying. You will pay your plan’s normal copay or a self-pay price such as $299–$499 via LillyDirect.
Is compounded tirzepatide legal now that shortages are over?
Compounding from bulk tirzepatide is no longer allowed once the drug leaves FDA’s shortage list. Pharmacies may still repackaged FDA-approved product for individual patients under section 503A, but most bulk-API vials are now considered unapproved.
How do I verify a compounding pharmacy’s license?
Check your state Board of Pharmacy website for 503A or 503B sterile licenses, and search the facility’s name on FDA’s Form 483 database for recent inspection findings.
Will Medicare Advantage plans still honor Lilly’s $50 cap?
Yes. The agreement applies to Medicare Part D and Medicare Advantage plans that include drug coverage, beginning April 1, 2026.
Can I switch from compounded tirzepatide to Zepbound without restarting titration?
Most patients can transition to the nearest lower FDA-approved dose, but confirm with your prescriber to avoid unexpected side effects. See our switching guide for dosing charts.
Connect with a Weight Loss Provider Today
Whether you choose brand-name Zepbound or a compounded alternative, the first step is a medical evaluation. Licensed U.S. clinicians on Rx.com can start your plan online in minutes.
